Exploring antibiotic safety: A prospective observational study from a tertiary care public sector hospital

被引:0
作者
Pavan, Garapati [1 ]
Kumar, Manish [2 ,3 ]
Dhingra, Sameer [1 ,4 ]
Kumar, Nitesh [5 ]
Ravichandiran, V [1 ]
Murti, Krishna [1 ,4 ]
机构
[1] Natl Inst Pharmaceut Educ & Res, Dept Pharm Practice, Hajipur, India
[2] Indira Gandhi Inst Med Sci, Dept Pharmacol, Patna, India
[3] Indira Gandhi Inst Med Sci, Adverse Drug React Monitoring Ctr, Patna, India
[4] Natl Inst Pharmaceut Educ & Res, Adverse Drug React Monitoring Ctr, Hajipur, India
[5] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Hajipur, India
来源
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH | 2024年 / 28卷
关键词
Antibiotics; ADR duration; Adverse drug reaction; Antimicrobial resistance; Stevens-johnson syndrome; ADVERSE DRUG-REACTIONS;
D O I
10.1016/j.cegh.2024.101592
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Antibiotics are the most commonly used drugs to treat bacterial infections; however, these lifesaving drugs can also cause adverse drug reactions. In several pharmacovigilance studies, adverse drug reactions are a cause of prolonged hospitalization. The development of hypersensitivity reactions even after a negative skin test and patch test makes antibiotic-associated adverse reactions unpredictable. Owing to the scarcity of data on antibiotic desensitization, these drugs are important for pharmacovigilance. Most of the previous studies conducted were retrospective and lacked data regarding the duration of adverse drug reactions. Aim: This study aimed to examine adverse drug reactions associated with antibiotics and to provide knowledge on the duration of these reactions. Method: A prospective observational study was conducted on patients receiving antibiotics at a tertiary care hospital. The patients were followed until discharge, and causality and severity assessments were performed. Descriptive statistical analyses were performed to summarize the data. Results: The study results show the median duration of adverse drug reactions was two days, with an interquartile range of two to four days. Most (21,3%) of the reactions were caused by cephalosporins. The majority (44.7%) of the reactions were skin and subcutaneous tissue disorders. The majority (78.7%) of the reactions were moderately severe and were not responsible for prolonged hospital stay. Conclusion: The patients receiving antibiotics require close monitoring for early detection and management of adverse reactions to reduce the duration of hospital stay and the duration of adverse drug reactions.
引用
收藏
页数:7
相关论文
共 31 条
[21]   Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis [J].
Murray, Christopher J. L. ;
Ikuta, Kevin Shunji ;
Sharara, Fablina ;
Swetschinski, Lucien ;
Aguilar, Gisela Robles ;
Gray, Authia ;
Han, Chieh ;
Bisignano, Catherine ;
Rao, Puja ;
Wool, Eve ;
Johnson, Sarah C. ;
Browne, Annie J. ;
Chipeta, Michael Give ;
Fell, Frederick ;
Hackett, Sean ;
Haines-Woodhouse, Georgina ;
Hamadani, Bahar H. Kashef ;
Kumaran, Emmanuelle A. P. ;
McManigal, Barney ;
Agarwal, Ramesh ;
Akech, Samuel ;
Albertson, Samuel ;
Amuasi, John ;
Andrews, Jason ;
Aravkin, Aleskandr ;
Ashley, Elizabeth ;
Bailey, Freddie ;
Baker, Stephen ;
Basnyat, Buddha ;
Bekker, Adrie ;
Bender, Rose ;
Bethou, Adhisivam ;
Bielicki, Julia ;
Boonkasidecha, Suppawat ;
Bukosia, James ;
Carvalheiro, Cristina ;
Castaneda-Orjuela, Carlos ;
Chansamouth, Vilada ;
Chaurasia, Suman ;
Chiurchiu, Sara ;
Chowdhury, Fazle ;
Cook, Aislinn J. ;
Cooper, Ben ;
Cressey, Tim R. ;
Criollo-Mora, Elia ;
Cunningham, Matthew ;
Darboe, Saffiatou ;
Day, Nicholas P. J. ;
De Luca, Maia ;
Dokova, Klara .
LANCET, 2022, 399 (10325) :629-655
[22]   Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017 [J].
Oshikoya, Kazeem Adeola ;
Ogunyinka, Ibrahim Abayomi ;
Ogar, Comfort Kunak ;
Abiola, Abiodun ;
Ibrahim, Ali ;
Oreagba, Ibrahim Adekunle .
THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11
[23]   Incidence of Adverse Drug Reactions in Indian Hospitals: A Systematic Review of Prospective Studies [J].
Patel, Tejas K. ;
Patel, Parvati B. .
CURRENT DRUG SAFETY, 2016, 11 (02) :128-136
[24]   Do Women Have More Adverse Drug Reactions? [J].
Marius Rademaker .
American Journal of Clinical Dermatology, 2001, 2 (6) :349-351
[25]   Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study [J].
Sharma, Megha ;
Baghel, Ruchi ;
Thakur, Sunil ;
Adwal, Sandeep .
BMJ OPEN, 2021, 11 (10)
[26]   Antibiotic-Related Adverse Drug Reactions in Patients Treated on the Dermatology Ward of Medical University of Gdansk [J].
Sokolewicz, Ewa Maria ;
Rogowska, Martyna ;
Lewandowski, Milosz ;
Puchowska, Monika ;
Piechota, Dorota ;
Baranska-Rybak, Wioletta .
ANTIBIOTICS-BASEL, 2021, 10 (10)
[27]   Clinical and economic impact of adverse drug reactions in hospitalized patients [J].
Suh, DC ;
Woodall, BS ;
Shin, SK ;
Hermes-De Santis, ER .
ANNALS OF PHARMACOTHERAPY, 2000, 34 (12) :1373-1379
[28]   Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis [J].
Sulis, Giorgia ;
Batomen, Brice ;
Kotwani, Anita ;
Pai, Madhukar ;
Gandra, Sumanth .
PLOS MEDICINE, 2021, 18 (07)
[29]   Clinical and economic burden of adverse drug reactions [J].
Sultana, Janet ;
Cutroneo, Paola ;
Trifiro, Gianluca .
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (05) :S73-S77
[30]   Study on the Classification, Causality, Preventability and Severity of Adverse Drug Reaction Using Spontaneous Reporting System in Hospitalized Patients [J].
Sundaran, Siraj ;
Udayan, Anjali ;
Hareendranath, Keerthi ;
Eliyas, Basil ;
Ganesan, Babu ;
Hassan, Ashik ;
Subash, Rajesh ;
Palakkal, Vishnu ;
Salahudeen, Mohammed Saji .
PHARMACY, 2018, 6 (04)